Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial
about
Efavirenz-based simplification after successful early lopinavir-boosted-ritonavir-based therapy in HIV-infected children in Burkina Faso and Côte d'Ivoire: the MONOD ANRS 12206 non-inferiority randomised trial.Young age at start of antiretroviral therapy and negative HIV antibody results in HIV-infected children when suppressed.Efavirenz is associated with higher bone mass in South African children with HIV.Decreased Vigorous Physical Activity in School-Aged Children with Human Immunodeficiency Virus in Johannesburg, South Africa.Extent of disclosure: what perinatally HIV-infected children have been told about their own HIV status.Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study.Antiretroviral treatment in HIV-infected children who require a rifamycin-containing regimen for tuberculosis.Empirical Consequences of Current Recommendations for the Design and Interpretation of Noninferiority Trials.Switching to Efavirenz Versus Remaining on Ritonavir-boosted Lopinavir in Human Immunodeficiency Virus-infected Children Exposed to Nevirapine: Long-term Outcomes of a Randomized Trial.Early age at start of antiretroviral therapy associated with better virologic control after initial suppression in HIV-infected infants.Impact of Human Immunodeficiency Virus Drug Resistance on Treatment of Human Immunodeficiency Virus Infection in Children in Low- and Middle-Income Countries.Reply to van de Wijer et. al.Substituting Abacavir for Stavudine in Children Who Are Virally Suppressed Without Lipodystrophy: Randomized Clinical Trial in Johannesburg, South Africa.Patterns of efavirenz use as first-line antiretroviral therapy in the United States: 1999-2015.Age at antiretroviral therapy initiation and cell-associated HIV-1 DNA levels in HIV-1-infected children.Decreased bone turnover in HIV-infected children on antiretroviral therapy.
P2860
Q33593775-8F7257B0-A1EA-44D3-A81D-78988C7A177DQ35962423-4DF70CF3-3B92-4D23-815F-D531DAB18136Q36079798-C3BEB8F8-CCFC-4D85-A0EE-570B56283ACEQ36839977-A52A273E-6602-44C4-A1B6-3CF8442D635BQ37653305-3BB2E135-978A-4D77-944E-712870A17900Q38798094-24C1C86E-7FB8-441D-8EF9-3EC25E9AF60CQ38874266-861CE442-BE99-4A73-9CB1-E87F435D9890Q40056576-F7243169-4D61-41F8-81C1-39FFB93AA309Q40238381-1D017E7F-D6DB-4F57-8851-B3ED99433ED8Q40458484-35236DF4-8A76-4B4A-A62F-497F92FE3C32Q45326130-66C1DBD2-F6CA-46F5-85DF-2D2657AB8192Q46699168-1169739C-AD5D-4B41-9285-0582F181DADDQ47548671-C1630C8A-0BA3-4165-80D3-7E75EC3919BCQ50051675-6C9D1783-DEE3-4E18-902E-F5DAC97C1E03Q52591828-116E6D8B-270F-4269-B90A-C9102DB8048EQ52603395-DB380F2F-7541-4802-BD10-9A5992013CA2
P2860
Efavirenz-Based Antiretroviral Therapy Among Nevirapine-Exposed HIV-Infected Children in South Africa: A Randomized Clinical Trial
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Efavirenz-Based Antiretroviral ...... a: A Randomized Clinical Trial
@ast
Efavirenz-Based Antiretroviral ...... a: A Randomized Clinical Trial
@en
type
label
Efavirenz-Based Antiretroviral ...... a: A Randomized Clinical Trial
@ast
Efavirenz-Based Antiretroviral ...... a: A Randomized Clinical Trial
@en
prefLabel
Efavirenz-Based Antiretroviral ...... a: A Randomized Clinical Trial
@ast
Efavirenz-Based Antiretroviral ...... a: A Randomized Clinical Trial
@en
P2093
P2860
P50
P356
P1476
Efavirenz-Based Antiretroviral ...... a: A Randomized Clinical Trial
@en
P2093
Faeezah Patel
Francoise Pinillos
Gillian Hunt
Leigh Martens
Wei-Yann Tsai
P2860
P304
P356
10.1001/JAMA.2015.13631
P407
P577
2015-11-01T00:00:00Z